Updates News Releases and Notices

News Release Code Compliance Promotion Committee

Announcement Regarding the “JPMA Code of Practice: Month to Promote Understanding of the JPMA Code”

News Release

Three Pharmaceutical Associations from Japan, the U.S., and Europe (
) Joint Statement on the Proposed Expansion of the Cost-Effectiveness Evaluation System

News Release Notices

The Japan Pharmaceutical Manufacturers Association to Transition to a General Incorporated Association Effective October 1, 2026
— Turning Change and Challenges into Strength. Expanding the Circle of Co-Creation. —

Notices Event Report

Public and Private Sectors to Highlight the Evolution of the Japanese Market and Clinical Trial Environment at “BIO International Convention 2026”

News Release Industry Policy Committee

JPMA Announces the 4th (FY 2026) “Call for Applications for Researcher Support and Grants”

Notices Patient Organization Collaboration Promotion Committee

We have posted the “Disclosed Information for FY 2025 Payments” under the “Transparency Guideline for Relationships Between Corporate Activities and Patient Organizations.”

Notices Code Compliance Promotion Committee

We have posted the “Disclosed Information for Fiscal Year 2025 Payments” under the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions, etc.”

Notices

We have posted the “Materials from the JPMA President’s Press Conference Held on July 30.”

Notices Public Relations Committee

We have published the “JPMA Newsletter, July 2026 Issue No. 230.”

News Release

Following the Cabinet’s Approval of the “Basic Policy 2026”

News Release

—Making Drug Discovery and Biotechnology Japan’s Engine of Growth— In Response to the Publication of the “Working Group Roadmap of the Japan Growth Strategy Council”

News Release Public Relations Committee

Five Member Companies of the JPMA Participate in “Girls Meet STEM” — Each Company Hosts Its Own Program —

News Release

Top Leaders of Global Biopharmaceutical Companies Meet with Prime Minister Sanae Takaichi

Notices Public Relations Committee

JPMA Newsletter May 2026 No.229" is now available.

News Release APAC Project

On the occasion of the 15th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference

News Release APAC Project

The 15th APAC Press Conference

News Release Drug Evaluation Committee

"Don't Take Medical and Health Information at Face Value!" Three Organizations Produce and Release Public Awareness Materials for the General Public

Notices Code Compliance Promotion Committee

Revision of the Transparency Guideline for the Relation between Corporate Activities and Medical Institutions

Notices

We have published the “FY 2026 Business Policy, Business Plan, and Implementation Plan.”

News Release

Notice Regarding the Appointment of New Officers

Notices

"DATA BOOK 2026" has been released.

Notices

"Materials from the JPMA President’s Press Conference Held on February 19" have been posted.

News Release Industry Policy Committee

Regarding “Recommendations on Intractable and Rare Diseases Based on a Survey of Healthcare Professionals’ Challenges”

Notices Public Relations Committee

JPMA Newsletter No. 228

Notices

New Year’s Greetings

News Release

In response to the FY2026 (Reiwa 8) Drug Price System Reform and Cost-Effectiveness Evaluation System Reform

News Release

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Opinions on the FY2026 (Reiwa 8) Drug Pricing System Reform and Cost-Effectiveness Evaluation System Reform

News Release Drug Evaluation Committee

Regarding the Release of the Joint Statement “Clinical Trial Ecosystem Industry Declaration 2025”

Notices International Committee

We have posted an announcement regarding the webinar “Toward the Formation of a Global Community to Promote Antimicrobial R&D.”

News Release Public Relations Committee

We won third place in the “My CareerStudy Course Contest 2025.” JPMA’s video course for undergraduate students received high praise from student judges.

Notices Public Relations Committee

"JPMA Newsletter No. 227" has been published.

Notices

We have published interview articles with the Chairpersons of the “ Toward Realizing the JPMA's Vision for 2035.”

News Release

On the Inauguration of New Prime Minister Sanae Takaichi

News Release Code Compliance Promotion Committee

Announcement Regarding the “JPMA Code of Practice: Month to Promote Understanding of the JPMA Code”

News Release

Participation in the “Kusuri Visionary Conference 2025”
Expanding the Circle of Stakeholders and Engaging in Discussions Toward Co-Creation

Notices

We have posted “My Theory of Leadership” from the Nikkei Shimbun.

Notices Code Compliance Promotion Committee

Regarding the Publication of the Book “JPMA Code of Practice (Revised May 2025)”

Notices Research and Development Committee

We have published “Scientific and Practical Requirements for Drug Candidates Sought by Companies: Regarding the Description in the Target Product Profile (TPP).”

News Release

Notice Regarding the Appointment of New Officers

News Release Public Relations Committee

[For Elementary School Students and Their Parents] Perfect for the fall long weekend! Hands-on events are being held at the National Museum of Science and Technology. “JPMA Kusurium Lab 2025 Fall” offers a fun way to learn about medicine. A social media campaign offering free invitations is also underway.

Notices Public Relations Committee

We have posted the “Science and Technology Museum ‘JPMA Kusurium Laboratory 2025 Fall’ Invitation Campaign!”

Notices Public Relations Committee

We have published “Understanding the Pharmaceutical Industry Through Manga: ‘Open Up! The World of Medicine Connecting to the Future.’”

Notices

We have posted a “Newspaper Advertisement.”

News Release Industry Policy Committee

Regarding the JPMA’s 3rd (FY 2025) “Open Call for Researcher Support and Grants”

Notices Patient Organization Collaboration Promotion Committee

We have updated the “Disclosed Information for FY 2024 Payments” in the “Transparency Guideline for Relationships Between Corporate Activities and Patient Organizations.”

Notices Code Compliance Promotion Committee

We have updated the “Disclosed Information for FY 2024 Payments” in the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions, etc.”

Notices

We have posted JPMA’s Vision for 2035 (English Version.)

Notices

We have posted JPMA’s Vision for 2035 (English Version.)

News Release Public Relations Committee

JPMA Sponsors the Sendenkaigi Award for Junior and Senior High School Students — Creating a Future for Life Together with the Young Generation Who Will Shape Tomorrow —

Notices Public Relations Committee

“JPMA Newsletter No. 226” has been published.

News Release Environmental Issues Review Committee

Selected for the Ministry of the Environment’s “Model Project to Promote Decarbonization Across the Entire Value Chain” — 12 Companies Participate to Develop Common CO2 Emissions Calculation Rules for the Pharmaceutical Industry

News Release

Following the Cabinet’s Approval of the “Basic Policy 2025”

Notices

We have posted the presentation video from the “Press Conference by the Chairman of the JPMA” held on May 22.

News Release Code Compliance Promotion Committee

Revision of the JPMA Code of Practice

Notices Public Relations Committee

We have posted the “JPMA Guide 2025.”

Notices

We have posted the “Materials from the JPMA President’s Press Conference Held on May 22.”

News Release

Notice Regarding the Appointment of New Officers

Notices

“Newspaper and Digital Advertising” has been updated.

Notices Public Relations Committee

"JPMA Newsletter No. 225" has been published.

Notices

“Newspaper and Digital Advertising” has been updated.

News Release APAC Project

Following the 14th Asia Pharmaceutical Association Cooperation Conference (APAC)

News Release APAC Project

We have posted the “Press Conference Materials for the 14th Asia Pharmaceutical Association Cooperation Conference (APAC), Held on April 23.”

Notices

We have published the FY2025 “Business Policy, Business Plan, and Implementation Plan.”

Notices Event Report

A report on the “JPMA Chairman’s Press Conference” has been posted.

Notices Code Compliance Promotion Committee

We have updated the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions”

Notices

We have published “DATA BOOK 2025.”

Notices

We have posted the presentation video from the “Press Conference by the Chairman of the JPMA” held on February 26.

Notices

We have posted the “Materials for the JPMA Chairman’s Press Conference Held on February 26.”

News Release

Regarding the “JPMA’s Vision for 2035” and “JPMA’s Policy Proposals for 2025”

News Release Public Relations Committee

Regarding the “18th Survey on Public Perceptions of Medicines and the Pharmaceutical Industry”

News Release Public Relations Committee

[For Elementary School Students and Their Parents] Aim to Become a Medicines Researcher This Spring Break! Announcement of the “JPMA Kusurium Laboratory,” a hands-on event where you can learn various facts about medicines

Notices Public Relations Committee

We have posted “Textbook: Pharmaceutical Industry 2024–2025.”

Notices Public Relations Committee

"JPMA Newsletter No. 224" has been published.

Notices Distribution Appropriateness Committee

We have updated the "FAQ Regarding Changes to the Industry Standard Manual 'EDI Unified Data Format' and the 8th System Upgrade of JD-NET."

News Release Drug Evaluation Committee

Release of an Awareness Video on the Utilization of Health and Medical Data

Notices APAC Project

A new “APAC Project” section has been added to the Committees page.

Notices

We have posted the “2025 New Year’s Greeting from the President of the JPMA.”

News Release

Regarding the FY2025 (Reiwa 7) Drug Price Revision

News Release

We have posted “Participation in the ‘Drug Visionary Conference 2024’
Aiming for Dialogue and Co-creation Among Diverse Stakeholders.”

Notices

We have posted the “Presentation Content and Key Q&A” from the Chairman’s Press Conference.

Notices Public Relations Committee

We have posted the booklet “Detective Medison and the Six Mysteries (2nd Edition).”

News Release Industry Policy Committee

Regarding the “Survey on Challenges Faced by Healthcare Professionals in Rare Diseases”

Notices Public Relations Committee

A new “Public Affairs Committee” has been added to the Committees page.

News Release Code Compliance Promotion Committee

Notice Regarding the “Code of Practice Understanding Promotion Month” for the JPMA

Notices Pharmaceutical Counseling and Response Review Committee

We have added a new "Consumer Consultation Review Committee" page to the Committee section.

Notices

We have posted the presentation video from the “October 8 Press Conference by the President of the JPMA.”

Notices

We have posted the “Materials from the JPMA President’s Press Conference Held on October 8.”

Notices Public Relations Committee

We have posted the “FY2024 JPMA PR and Communications Plan.”

Notices Public Relations Committee

"JPMA Newsletter No. 223" has been published.

News Release Industry Policy Committee

JPMA 2nd (FY 2024) “Open Call for Proposals Regarding Researcher Support and Grants”

Notices Public Relations Committee

"JPMA Newsletter No. 222" has been published.

News Release

Regarding the “Initiatives to Eliminate Drug Loss” proposed at the Ministry of Health, Labor and Welfare’s Conference on Unapproved Drugs and Off-Label Drugs with High Medical Need

Notices Code Compliance Promotion Committee

We have updated the “Publicly Disclosed Information for FY2023 Payments” under the “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions, etc.”

Notices Public Relations Committee

We have published the “JPMA Guide 2024.”

Notices Public Relations Committee

"JPMA Newsletter No. 221" has been published.

News Release APAC Project

Following the “13th Asia Pharmaceutical Association Cooperation Conference”

News Release APAC Project

Press Conference Materials for the 13th Asia Pharmaceutical Association Conference (APAC)

Notices Drug Evaluation Committee

"Glossary of Health and Medical Data" has been posted.

Notices Research and Development Committee

"R & D Needs of Research Committee Member Companies" has been posted.

Notices

We have published the FY2024 “Business Policy, Business Plan, and Implementation Plan.”

Notices Public Relations Committee

"JPMA Newsletter No. 220" has been published.

News Release Public Relations Committee

The second installment of the awareness-raising event in the pharmaceutical and medical fields, “Living with Illness. Living with Hope. Photo Exhibition—Toward a Future That Creates Answers We Have Yet to See,” was held in Osaka.

Notices

We have published the newspaper advertisement “Let’s Think About Rare Diseases—Toward a Society of Understanding.”

Notices

“DATA BOOK 2024” has been released.

Notices

We have posted the presentation video from the “Press Conference by the President of the JPMA” held on February 15.

News Release

We have posted the “Materials from the JPMA President’s Press Conference Held on February 15.”

Notices Public Relations Committee

“JPMA Newsletter No. 219” has been published.

Notices

Regarding the Reiwa 6 Noto Peninsula Earthquake

Notices

We have posted the “2024 New Year’s Greeting from the President of the JPMA.”

Notices

We have posted a “Newspaper Advertisement.”

News Release Public Relations Committee

About the “17th Public Awareness Survey on Medicines and the Pharmaceutical Industry”

News Release

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Joint Statement on the FY2024 (Reiwa 6) Drug Pricing System Reform and Cost-Effectiveness Evaluation System Reform

News Release Public Relations Committee

We have posted the presentation materials from the awareness-raising event in the pharmaceutical and medical fields, “Living with Illness. Living with Hope. Photo Exhibition—Toward a Future That Creates Answers Yet to Be Discovered.”

Notices Public Relations Committee

“JPMA Newsletter No. 218” has been published.

Notices Distribution Appropriateness Committee

We have updated the “Industry Standard Manual.”

News Release Code Compliance Promotion Committee

Notice Regarding the “Code of Practice Understanding Promotion Month” for the JPMA

Notices Code Compliance Promotion Committee

The initiative “Consensus Framework for Ethical Collaboration in Japan” received the “2023 The Lighthouse Award.”

Notices Review Board of Ethical Drug Product Information Brochure

We have posted the revised version of the “Guidelines for Preparing Summaries of Product Characteristics for Prescription Drugs.”

Notices Public Relations Committee

"JPMA Newsletter No. 217" has been published.

News Release Industry Policy Committee

Regarding the JPMA’s “Open Call for Researcher Support and Grants”

Notices Distribution Appropriateness Committee

"FAQ Regarding Changes to the EDI Standard Data Format" has been posted.

Notices Distribution Appropriateness Committee

We have updated the “Industry Standard Manual.”

News Release Industry Policy Committee

Regarding the JPMA’s “Proposals on Intractable and Rare Diseases”

Notices Public Relations Committee

“JPMA Newsletter No. 216” has been published.

News Release

We published a joint statement by three pharmaceutical industry organizations from Japan, the U.S., and Europe regarding the “Draft Report of the Expert Panel on Comprehensive Measures to Ensure the Rapid and Stable Supply of Pharmaceuticals”

Notices

We have posted the presentation video from the “Press Conference by the President of the JPMA” held on May 25.

Notices Public Relations Committee

We have posted the “JPMA Guide 2023.”

News Release

Notice Regarding the Appointment of New Officers

Notices Public Relations Committee

"JPMA Newsletter No. 215" has been published.

Notices

"Newspaper Ads" and "Digital Ads" have been posted.

News Release

We have posted “Revision of the Classification of COVID-19 Under the Infectious Diseases Control Law.”

News Release Drug Evaluation Committee

We have posted “Announcement Regarding the Release of ‘Health and Medical Data and Our Lives,’ an Awareness Brochure for the General Public on the Use of Health and Medical Data.”

Notices Drug Evaluation Committee

We have published “Health and Medical Data and Our Lives.”

Notices Code Compliance Promotion Committee

We have revised the “JPMA Compliance Program Guidelines.”

News Release Industry Policy Committee

We have posted “Research and Recommendations on the Pharmaceutical Industry’s Contribution to Extending Healthy Life Expectancy and Driving Economic Growth—Toward the Future of the Pharmaceutical Industry.”

News Release APAC Project

“Following the ‘12th Asia Pharmaceutical Association Cooperation Conference’” has been posted.

News Release APAC Project

We have posted “Press Conference Materials for the 12th Asia Pharmaceutical Association Cooperation Conference (APAC), Held on April 19.”

News Release

We have posted the joint statement by three pharmaceutical associations from Japan, the U.S., and Europe titled “Proposals for the FY2024 (Reiwa 6) Drug Pricing System Reform.”

Notices

We have published the “FY 2023 Business Policy, Business Plan, and Implementation Plan.”

Notices Public Relations Committee

"JPMA Newsletter No. 214" has been published.

Notices

We have published “DATA BOOK 2023.”

Notices

We have posted the “Video of the Presentation from the JPMA Chairman’s Press Conference Held on February 16.”

Notices

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on February 16.”

News Release

We have posted the “JPMA Policy Proposals 2023.”

News Release Industry Policy Committee

Regarding the JPMA “Survey on Challenges Faced by Patients with Rare Diseases”

Notices

We have posted a “Newspaper Advertisement.”

Notices

We have posted a “Newspaper Advertisement.”

Notices Environmental Issues Review Committee

We have established a new “Environmental Issue Committee.”

Notices Public Relations Committee

"JPMA Newsletter No. 213" has been published.

Notices

We have posted the “2023 New Year’s Greeting from the President of the JPMA.”

Notices Industry Policy Committee Public Relations Committee

We have posted the PIVOT tie-in video “& questions | What Is Innovation That Will Change Japan?”

News Release

Joint Statement by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Regarding the FY2023 (Reiwa 5) Drug Price Revision

Notices Public Relations Committee

“Textbook: Pharmaceutical Industry 2022–2023” has been published.

News Release Public Relations Committee

About the “16th Survey on Public Perceptions of Medicines and the Pharmaceutical Industry”

News Release

We have published the “Joint Opinion on Mid-Year Drug Price Revisions” by three pharmaceutical industry associations from Japan, the U.S., and Europe.

Notices

"Opinion on Access to and Benefit-Sharing of Digital Sequence Information" has been published.

Notices Public Relations Committee

"JPMA Newsletter No. 212" has been published.

News Release

Following the Cabinet’s approval of the “Second Supplementary Budget Bill for Reiwa 4,”

News Release International Committee

Proposals from the Pharmaceutical Industry for the G7 Hiroshima Summit Health Agenda:

Notices

Following the Cabinet’s approval of the “Comprehensive Economic Measures to Overcome Rising Prices and Achieve Economic Revitalization”—Statement by the President of the JPMA has been posted.

News Release Code Compliance Promotion Committee

We have posted “Notice Regarding the ‘Code of Practice Understanding Promotion Month’ for the JPMA Code of Practice.”

News Release

We have posted an article titled “Collaboration Among the University of Tokyo, Tokyo Medical and Dental University, and the JPMA at the Greater Tokyo Biocommunity (GTB) Hongo, Ochanomizu, and Tokyo Station Area Hub.”

News Release

"Appointment of New Board Members" has been posted.

Notices Public Relations Committee

"JPMA Newsletter No. 211" has been published.

Notices

We have posted the “Video of the Presentation from the JPMA Chairman’s Press Conference Held on August 30.”

Notices

We have posted the “Materials from the JPMA Chairman’s Press Conference Held on August 30.”

Notices Industry Policy Committee

We have posted the presentation materials from the “JPMA Media Forum (held July 19, 2022).”

Notices Public Relations Committee

"JPMA Newsletter No. 210" has been published.

News Release

Toward Building an Ecosystem to Enhance Japan’s Drug Discovery Capabilities

Notices

An interview with the President of the JPMA, “The Vision We Seek for Japan Now That We Have Experienced COVID-19,” has been posted in the “Magazine” category.

News Release Intellectual Property Committee

Regarding the Agreement on Exemptions from Intellectual Property Protection Obligations (TRIPS Waiver) at the 12th WTO Ministerial Conference

News Release Industry Policy Committee

Jointly produced and released by the Council for the Proper Use of Medicines and the Japan Pharmaceutical Manufacturers Association: An educational video on polypharmacy titled “How Many Medications Are You Taking?”

News Release

We have posted the “Statement by the R&D-Based Pharmaceutical Industry on the Discussions Scheduled for the 12th WTO Ministerial Conference Regarding Exemptions from Intellectual Property Protection Obligations.”

Notices Public Relations Committee

We have published the “JPMA Guide 2022.”

Notices Patient Organization Collaboration Promotion Committee

We have updated the “About the Transparency Guideline” section of the Guidelines on Transparency in Relationships Between Companies and Patient Organizations.

Notices Public Relations Committee

"JPMA Newsletter No. 209" has been published.

News Release

We have posted “Proposal by Three Pharmaceutical Associations from Japan, the U.S., and Europe: Joint Proposal for Formulating the ‘Basic Policy’ and ‘Growth Strategy’.”

Notices

We have posted a “Newspaper Advertisement.”

Notices

We have published “Digital Advertising.”

News Release

Discussions at the WTO on Exemptions from Intellectual Property Protection Obligations

News Release APAC Project

We have posted “Press Conference Materials for the 11th Asia Pharmaceutical Association Conference (APAC), Held on April 6.”

News Release APAC Project

“Reflections on the ‘11th Asia Pharmaceutical Association Cooperation Conference’” has been posted.

Notices

We have released the “Business Policy, Business Plan, and Implementation Plan” for fiscal year 2022.

Notices

We have posted a “Newspaper Advertisement.”

News Release Drug Evaluation Committee

We have published “Three Organizations Related to Clinical Trials Jointly Formulate a ‘Data Integrity Declaration’.”

Notices Code Compliance Promotion Committee

We have posted the “Transparency Guideline: English Version (Revised January 20, 2022).”

Notices

"DATA BOOK 2022 (English)" has been published.

Notices Public Relations Committee

"JPMA Newsletter No. 208" has been published.

Notices Public Relations Committee

We have released “YELL for New Drugs,” a collaboration with Tokyo Graffiti.

Notices Public Relations Committee

We have published videos #5–#8 of “Learning About New Drug Innovation with Pharmacy Student Aoi.”

Notices

"DATA BOOK 2022 (Japanese)" has been published.

News Release

Joint Statement Released: “Three Priorities for Urgently Expanding Access to COVID-19 Vaccines”

Notices

"JPMA Video Content" has been updated.

News Release Public Relations Committee

FY2021 JPMA Communication Plan

Notices Code Compliance Promotion Committee

The “Transparency Guideline (Revised January 20, 2022)” have been posted.

Notices Public Relations Committee

We have posted the “Announcement Regarding the Launch of the JPMA’s Official Twitter Account.”

Notices Public Relations Committee

Videos #1–#4 of “Learning About New Drug Innovation with Pharmacy Student Aoi” have been released.

Notices

"Materials from the January 20 Press Conference by the Chairman of the JPMA" have been posted.

Notices Public Relations Committee

“JPMA Newsletter No. 207” has been published.

Notices

New Year’s Greetings from the President of the JPMA, 2022

News Release

Reiwa 4 Pharmaceutical Price System Reform

Notices Public Relations Committee

The Asahi Shimbun’s “Job Yearbook 2021” has been posted.

News Release Public Relations Committee

Regarding the “15th Public Awareness Survey on Medicines and the Pharmaceutical Industry”

Notices Public Relations Committee

We have released the “15th Public Awareness Survey on Medicines and the Pharmaceutical Industry.”

Notices Public Relations Committee

"JPMA Newsletter No. 206" has been published.

News Release Code Compliance Promotion Committee

We have posted “Notice Regarding the ‘Code of Practice Understanding Promotion Month’ for the JPMA Code of Practice.”

News Release

A new “List of Non-Financial Information Disclosures” (link collection) for member companies of the JPMA has been added.

Notices

We have posted a “Newspaper Advertisement.”

Notices ICH Project

Information on the “ICH Quality Forum” has been posted.

Notices Public Relations Committee

"JPMA Newsletter No. 205" has been published.

News Release

Following the Announcement of the “Pharmaceutical Industry Vision 2021”

News Release

JPMA website has been redesigned.

Notices International Committee Public Relations Committee

We have posted the “JPMA Guide 2021 (English and Chinese Editions).”

Notices International Committee

The “IFPMA Vaccines Confidence Digital Campaign” has been updated.

News Release

Disciplinary Actions Against Member Companies

Notices Public Relations Committee

“JPMA Newsletter No. 204” has been published.

Notices Drug Evaluation Committee

"YouTube Video: Innovative Changes in Data Management" has been posted.

Notices Public Relations Committee

"JPMA Guide 2021" has been posted.

News Release

“Materials from the JPMA Chairman’s Press Conference Held on May 20” have been posted.

Notices

We have updated the “Chairman’s Message” and “List of Officers.”

Notices

Notice Regarding the Appointment of New Officers

News Release

Regarding the “JPMA Industry Vision 2025: Supplement”

Notices Public Relations Committee

"JPMA Newsletter No. 203" has been published.

News Release

Regarding the Waiver of Intellectual Property Rights at the WTO

Notices

We have posted a “Newspaper Advertisement.”

News Release APAC Project

Following the 10th Asia Pharmaceutical Association Collaboration Conference

Notices

We have released the FY2021 “Business Policy, Business Plan, and Implementation Plan.”

Notices

We have published the “DATA BOOK 2021 (English Edition).”

Notices Public Relations Committee

We have published “Textbook: Pharmaceutical Industry 2020–2021.”

Notices

We have posted materials from the “Press Conference by the Chairman of the JPMA.”

Notices

We have published “JPMA Policy Proposals 2021.”

Notices

"DATA BOOK 2021 (Japanese)" has been published.

Notices Public Relations Committee

"JPMA Newsletter No. 202" has been published.

Notices Drug Evaluation Committee

We have published the 5th edition of “Medicines and Clinical Trials.”

News Release Research and Development Committee

"National Center Biobank Network and Japan Pharmaceutical Manufacturers Association Member Companies Launch Industry-Academia-Government Collaboration on the Construction and Utilization of a Disease-Specific Integrated Database—Toward the Early Implementation of Precision Medicine, Prevention, and Proactive Healthcare" has been posted.

Notices Public Relations Committee

"JPMA Newsletter No. 201" has been published.

News Release

“Measures to Combat the Spread of COVID-19—In Response to the Declaration of a State of Emergency”